IMMUNIC, INC. - 8-K Filing
Immunic, Inc. reports Q3 2026 results and announces top-line data for Phase 3 ENSURE trials expected in December 2026. (Items: 2.02 Results of Operations and Financial Condition On November 13, 2026, Immunic, Inc, 9.01 Financial Statements and Exhibits Exhibit Description 99)